Random Homozygous Gene Perturbation (RHGP) as a Tool for Target Discovery and Validation

Poster   Sep 24, 2012

 
Random Homozygous Gene Perturbation (RHGP) as a Tool for Target Discovery and Validation
 
View Poster
 
 

Wu-Bo Li and Michael Goldblatt

 
 

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License

 
View Poster
 
 
 

OTHER POSTERS

Is Oxford Nanopore Technology Ready for Clinical Diagnostics?

Poster

Our objective is to validate diagnostic services using Oxford Nanopore’s Minion in the first instance and to evaluate the cost and performance compared to existing sequencing technology in areas such as tumour DNA sequencing (and circulating tumour DNA), virology, microbiology, genetics and HLA-typing.

READ MORE

Performance of the D5000 and High Sensitivity D5000 ScreenTape Assays for the 4200 TapeStation System

Poster

Here, we focus on quantification, sizing, and sensitivity of both D5000 ScreenTape assays.

READ MORE

CiPA Phase 2 Study: validation of an automated microelectrode array (MEA) assay of hiPSC-derived cardiomyocyte electrophysiology for cardiac safety evaluation

Poster

These results support the use of hSC-CM and MEA technology for preclinical assessment of proarrhythmic risk within the proposed CiPA paradigm, and, more generally, demonstrate that automation of the CM-MEA assay can achieve high reliability and throughput for cardiac risk assessment in vitro.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE